Second annual GPCRs: from orphan to blockbuster.

Area of Science:

• Pharmacology and drug discovery
• Molecular biology and biochemistry

Background:

• G-protein-coupled receptors (GPCRs) represent a critical class of drug targets.
• Significant challenges remain in understanding GPCRs and developing effective therapeutics.

Framework:

• The meeting focused on key areas: GPCR structure, endogenous ligand identification, and high-throughput screening (HTS) methodologies.
• Discussions covered the transition from screening hits to viable drug leads.
• Strategies for robust proof-of-principle studies were also addressed.

Implementation:

• Academia and industry scientists convened to share insights and address challenges in GPCR research.
• Two days of talks facilitated discussion on novel approaches and current limitations.
• The report synthesizes key takeaways from these collaborative efforts.

Implications:

• Advancing GPCR-targeted drug discovery is crucial for developing novel therapeutics.
• Improved understanding of GPCRs and screening methods can accelerate the identification of effective drug candidates.
• This collaborative approach fosters innovation in addressing unmet medical needs through GPCR modulation.